|
1. De Falco, F. A., et al. Effect of the chronic treatment with L-acetylcarnitine
in Down’s syndrome. Clin Ther. 144:123-127, 1994.
2. Bowman, B. Acetyl-carnitine and Alzheimer’s disease. Nutr Rev.
50:142-144, 1992.
3. Bruno, G., et al. Acetyl-L-carnitine in Alzheimer disease: a short-term
study on CSF neurotransmitters and neuropeptides. Alzheimer Dis Assoc
Disord (USA). 9(3):128-131, 1995.
4. Calvani, M., et al. Action of acetyl-L-carnitine in neurodegeneration
and Alzheimer’s disease. Annals of the New York Academy of Sciences
(USA). 663:483-486, 1993.
5. Carta, A., et al. Acetyl-L-carnitine: a drug able to slow the progress
of Alzheimer’s Disease? Annals of the New York Academy of Sciences
(USA. 640:228-232, 1991.
6. Guarnaschelli, C., et al. Pathological brain ageing: evaluation of
the efficacy of a pharmacological aid. Drugs under Experimental and Clinical
Research. 14(11):715-718, 1988.
7. Passeri, M., et al. Acetyl-L-carnitine in the treatment of mildly
demented elderly patients. International Journal of Clinical Pharmacology
Research. 10(1-2):75-79, 1990.
8. Pettegrew, J. W., et al. Clinical and neurochemical effects of acetyl-L-carnitine
in Alzheimer’s disease. Neurobiol Aging. 16:1-4, 1995.
Rai, G., et al. Double-blind, placebo controlled study of acetyl-L-carnitine
in patients with Alzheimer’s dementia. Current Medical Research
and Opinion. 11(10):638-647, 1989.
9. Sano, M., et al. Double-blind parallel design pilot study of acetyl
levocarnitine in patients with Alzheimer’s disease. Arch Neurol.
49:1137-1141, 1992.
10. Sinforiani, E., et al. Neuropsychological changes in demented patients
treated with acetyl-L-carnitine. International Journal of Clinical Pharmacology
Research. 10(1-2):69-74, 1990.
11. Spagnoli, A. U., et al. Long-term acetyl-l-carnitine treatment in
Alzheimer’s disease. Neurology. 41(11):1726-1732, 1991.
|